To include your compound in the COVID-19 Resource Center, submit it here.
CYTR acquired the clinical and pharmaceutical assets of Biorex for $3 million in cash. The deal brings
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury